GeoWealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.67M Buy
14,601
+425
+3% +$91.4K 0.12% 107
2026
Q1
$3.08M Sell
14,176
-2,271
-14% -$504K 0.11% 116
2025
Q4
$3.76M Buy
16,447
+170
+1% +$38.7K 0.14% 99
2025
Q3
$3.77M Sell
16,277
-379
-2% -$77.2K 0.14% 101
2025
Q2
$3.09M Sell
16,656
-187
-1% -$34.8K 0.12% 101
2025
Q1
$3.53M Sell
16,843
-2,624
-13% -$510K 0.14% 94
2024
Q4
$3.46M Buy
19,467
+675
+4% +$124K 0.11% 122
2024
Q3
$3.71M Sell
18,792
-650
-3% -$121K 0.13% 126
2024
Q2
$3.33M Sell
19,442
-3,679
-16% -$609K 0.15% 105
2024
Q1
$4.21M Buy
23,121
+7,539
+48% +$1.3M 0.16% 109
2023
Q4
$2.41M Buy
15,582
+7,240
+87% +$1.06M 0.2% 105
2023
Q3
$1.24M Buy
8,342
+6,179
+286% +$907K 0.14% 125
2023
Q2
$292K Buy
2,163
+42
+2% +$6.16K 0.03% 213
2023
Q1
$339K Sell
2,121
-285
-12% -$43.6K 0.04% 166
2022
Q4
$389K Sell
2,406
-1,383
-37% -$212K 0.04% 166
2022
Q3
$512K Buy
3,789
+636
+20% +$91.3K 0.06% 162
2022
Q2
$483K Buy
3,153
+2,887
+1,085% +$441K 0.06% 163
2022
Q1
$43K Sell
266
-492
-65% -$71.5K ﹤0.01% 341
2021
Q4
$103K Buy
758
+501
+195% +$59.2K 0.01% 308
2021
Q3
$28K Sell
257
-387
-60% -$44.2K ﹤0.01% 344
2021
Q2
$73K Buy
+644
New +$72.5K 0.01% 226

Other funds holding ABBV

GeoWealth Management's ABBV Position: Q2 2026 in Review

GeoWealth Management increased its AbbVie (ABBV) stake by 3% in Q2 2026, buying an estimated $91.4K and bringing the position to 14,601 shares worth $3.67M. The position accounts for 0.12% of the portfolio, ranked #107.

GeoWealth Management first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.21M in Q1 2024. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • GeoWealth Management held 14,601 shares of AbbVie worth $3.67M as of Q2 2026.
  • GeoWealth Management bought 425 AbbVie shares in Q2 2026, an estimated $91.4K.
  • AbbVie made up 0.12% of GeoWealth Management's portfolio in Q2 2026, its #107 holding.
  • GeoWealth Management first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
  • GeoWealth Management's AbbVie position peaked at $4.21M in Q1 2024.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GeoWealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.